RICARDO CORREA BARBUTI
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
11 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 11
conferenceObject Esophagogastroduodenal Mucosal Behavior after Bronchial Challenge with House Dust Mites in Allergic Asthmatic Patients(2015) AGONDI, Rosana C.; NAVARRO-RODRIGUEZ, Tomas; BARBUTI, Ricardo; BISACCIONI, Carla; AUN, Marcelo Vivolo; KALIL, Jorge; GIAVINA-BIANCHI, Pedro- Probiotics intake and metabolic syndrome: A proposal (Retracted article. See vol. 39, pg. 85, 2014)(2011) BOGSAN, Cristina Stewart B.; FLORENCE, Ana Carolina R.; PERINA, Natalia; BARBUTI, Ricardo C.; NAVARRO-RODRIGUEZ, Tomas; EISIG, Jaime N.; OLIVEIRA, Marice N.Probiotics are practical tools to provide the modulation of microbiota. The ingestion of food or ingredients containing anti-inflammatory activity components as probiotics should be useful in obesity control and associated co-morbidities treatment. Metabolic syndrome is a metabolic dysfunction associated with visceral obesity and insulin resistance, in which the alterations in host microbiota interactions play an important role. Besides diet and physical activity, new strategies are necessary to control metabolic syndrome, and as consequence improving quality of life. This article revises the actual knowledge concerning probiotic intake and obesity as a proposal to control metabolic syndrome.
- Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease(2012) DAL-PAZ, K.; MORAES-FILHO, J. P.; NAVARRO-RODRIGUEZ, T.; EISIG, J. N.; BARBUTI, R.; QUIGLEY, E. M. M.To assess adherence to proton pump inhibitor (PPI) treatment and associated variables in patients with gastroesophageal reflux disease (GERD). Cross-sectional and prospective comprising 240 consecutive adult patients, diagnosed with GERD for whom continuous use of standard or double dose of omeprazole had been prescribed. Patients were ranked as ne-GERD (162: 67.5%) or e-GERD classified according to the Los Angeles classification as A (48:20.0%), B (21:8.6%), C (1:0.5%), D (1:0.5%), and Barrett's esophagus (7:2.9%). The Morisky questionnaire was applied to assess adherence to therapy and a GERD questionnaire to assess symptoms and their impact. Adherence was correlated with demographics, cotherapies, comorbidities, treatment duration, symptoms scores, endoscopic findings, and patient awareness of their disease. 126 patients (52.5%) exhibited high level of adherence and 114 (47.5%) low level. Youngers (P= 0.002) or married (O.R. 2.41, P= 0.03 vs. widowers) patients had lower levels of adherence; symptomatic patients exhibited lower adherence (P= 0.02). All other variables studied had no influence on adherence. Patients with GERD attending a tertiary referral hospital in Sao Paulo exhibited a high rate of low adherence to the prescribed PPI therapy that may play a role in the therapy failure. Age <60 years, marital status and being symptomatic were risk factors for low adherence.
bookPart Sindrome do Intestino Irritável(2016) BARBUTI, Ricardo Correa; AZEVEDO, Matheus Freitas Cardoso de; MORAES FILHO, Joaquim Prado Pinto deconferenceObject Diabetes and Dislipidemia Increase Significantly the Risk of Gastric Intestinal Metaplasia: A Prospective Study(2015) NAVARRO-RODRIGUEZ, Tomas; BARBUTI, Ricardo C.; EISIG, Jaime N.; DIB, Ricardo A.; ABRANTES, Eduardo F.; RIBEIRO, Karina B.; REIS, Luiz Fernando L.; MONTAGNINI, Andre L.conferenceObject Bifidobacterium Lactis B420/Streptococcus thermophilus TA040-Fermented Milk Improves Dyspepsia. A Prospective, Randomized, Double-Blind Trial(2014) BARBUTI, Ricardo C.; OLIVEIRA, Marice N.; PERINA, Natalia P.; HARO, Christiane; BOGSAN, Cristina S.; EISIG, Jaime N.; NAVARRO-RODRIGUEZ, TomysbookPart Síndrome de zollinger-ellison (gastrinoma)(2013) BARBUTI, Ricardo C.conferenceObject Standard Triple Therapy for Helicobacter pylori Is Still the Best First Line Treatment in Brazil, Compared With Sequential Therapy: A Randomized, Prospective, Double-Blind, Placebo-Controlled Study(2014) EISIG, Jaime N.; NAVARRO-RODRIGUEZ, Tomas; TEIXEIRA, Ana Cristina; SILVA, Fernando M.; MATTAR, Rejane; CHINZON, Decio; MORAES-FILHO, Joaquim P.; HARO, Christiane; BARBUTI, Ricardo C.- Probiotics intake and metabolic syndrome: A proposal (Retraction of vol 22, pg 457, 2011)(2014) BOGSAN, Cristina Stewart B.; FLORENCE, Ana Carolina R.; PERINA, Natalia; BARBUTI, Ricardo C.; NAVARRO-RODRIGUEZ, Tomas; EISIG, Jaime N.; OLIVEIRA, Marice N.
conferenceObject Is the incidence of gastric tumor increasing in variable common immunodeficiency patients?(2019) GRECCO, O.; BARBUTI, R. C.; KOKRON, C. M.; MARINHO, A. K. B.; SINI, B. C.; FIGUEIRA, R. C. L.; KALIL, J.; BARROS, M. T.